DRUG SAFETY ALERT The U.S. Food and Drug Administration (FDA) has issued a safety alert on Avandia, a drug used to treat type 2 diabetes. Several clinical trials have shown that there is a significant increase in the risk of heart attack and heart related deaths in patients taking Avandia. The drug is manufactured and marketed by GlaxoSmithKline. It was approved by the FDA in 1999, and more than one million people have taken the drug in the U.S. alone. Avandia has been heavily promoted to consumers, and some believe that GlaxoSmithKline should have known of the potential risks and warned those taking the drug. According to the FDA, “Patients who are taking Avandia, especially those who are known to have underlying heart disease or who are at high risk of heart attack should talk to their doctor about this new information as they evaluate the available treatment options for their type 2 diabetes.” If you or a loved one has suffered a heart problem that you believe is related to Avandia, be sure to contact our office. WE APPRECIATE YOU If you are interested in receiving help on your potential case, please contact us for Free Case Evaluation (Secure Online) or call The Brooks Law Group at 1-888-We-Mean-It. Please be sure to provide us with as much information as is reasonably available. The quality of our evaluation is dependent upon the accuracy of the information you provide to us. Any initial consultation with the Brooks Law Group is free. For more information, call us at 1-888-We-Mean-It, or by e-mail. |
|
Email: info@brookslawgroup.com
Phone: 1-888-We-Mean-It
123 First Street North | Winter Haven, FL 33881
115 South Newport Ave. | Tampa, FL 33606
